Matches in Wikidata for { <http://www.wikidata.org/entity/Q37554942> ?p ?o ?g. }
- Q37554942 description "article científic" @default.
- Q37554942 description "article scientifique" @default.
- Q37554942 description "articolo scientifico" @default.
- Q37554942 description "artigo científico" @default.
- Q37554942 description "artículu científicu espublizáu en 2013" @default.
- Q37554942 description "bilimsel makale" @default.
- Q37554942 description "scientific article published on 02 July 2013" @default.
- Q37554942 description "vedecký článok" @default.
- Q37554942 description "vetenskaplig artikel" @default.
- Q37554942 description "videnskabelig artikel" @default.
- Q37554942 description "vědecký článek" @default.
- Q37554942 description "wetenschappelijk artikel" @default.
- Q37554942 description "wissenschaftlicher Artikel" @default.
- Q37554942 description "наукова стаття, опублікована в липні 2013" @default.
- Q37554942 description "научни чланак" @default.
- Q37554942 description "مقالة علمية نشرت في 02 يوليو 2013" @default.
- Q37554942 name "Phase 1 dose-escalation, pharmacokinetic, and cerebrospinal fluid distribution study of TAK-285, an investigational inhibitor of EGFR and HER2." @default.
- Q37554942 name "Phase 1 dose-escalation, pharmacokinetic, and cerebrospinal fluid distribution study of TAK-285, an investigational inhibitor of EGFR and HER2." @default.
- Q37554942 name "Phase 1 dose-escalation, pharmacokinetic, and cerebrospinal fluid distribution study of TAK-285, an investigational inhibitor of EGFR and HER2." @default.
- Q37554942 type Item @default.
- Q37554942 label "Phase 1 dose-escalation, pharmacokinetic, and cerebrospinal fluid distribution study of TAK-285, an investigational inhibitor of EGFR and HER2." @default.
- Q37554942 label "Phase 1 dose-escalation, pharmacokinetic, and cerebrospinal fluid distribution study of TAK-285, an investigational inhibitor of EGFR and HER2." @default.
- Q37554942 label "Phase 1 dose-escalation, pharmacokinetic, and cerebrospinal fluid distribution study of TAK-285, an investigational inhibitor of EGFR and HER2." @default.
- Q37554942 prefLabel "Phase 1 dose-escalation, pharmacokinetic, and cerebrospinal fluid distribution study of TAK-285, an investigational inhibitor of EGFR and HER2." @default.
- Q37554942 prefLabel "Phase 1 dose-escalation, pharmacokinetic, and cerebrospinal fluid distribution study of TAK-285, an investigational inhibitor of EGFR and HER2." @default.
- Q37554942 prefLabel "Phase 1 dose-escalation, pharmacokinetic, and cerebrospinal fluid distribution study of TAK-285, an investigational inhibitor of EGFR and HER2." @default.
- Q37554942 P1433 Q37554942-4F783F8B-29AD-41C3-A395-E430A8BD10B6 @default.
- Q37554942 P1476 Q37554942-48F5CE4A-7512-4B22-A530-30874742FC56 @default.
- Q37554942 P2093 Q37554942-03957DFE-C9D9-4ED0-9643-C6D39E56DBE0 @default.
- Q37554942 P2093 Q37554942-09B08EB6-F04D-47BE-840B-A579CE742A41 @default.
- Q37554942 P2093 Q37554942-25CBF2A4-1CD5-47CB-AD13-51CCCDB88999 @default.
- Q37554942 P2093 Q37554942-7AAFF639-3E4C-47C3-92C1-F2727E013E73 @default.
- Q37554942 P2093 Q37554942-A73048EF-ACAF-4ACE-9E4F-40E95603B552 @default.
- Q37554942 P2093 Q37554942-ADBF1503-5301-4A08-8ACD-BF28E87B9412 @default.
- Q37554942 P2093 Q37554942-E234362D-6C77-4E98-A634-6A9D894B53EB @default.
- Q37554942 P2093 Q37554942-FDFD5360-C88C-494B-ADDC-B894B7823982 @default.
- Q37554942 P275 Q37554942-fe36a20f-2179-4bf7-9b97-455eb213f9dc @default.
- Q37554942 P2860 Q37554942-13D7EA9D-A4FA-49BC-957C-D505E0D228C8 @default.
- Q37554942 P2860 Q37554942-1A1AF372-A486-4B71-BD10-A490C1007E5C @default.
- Q37554942 P2860 Q37554942-20E69A53-3A7C-4B10-837E-70F57F5A003C @default.
- Q37554942 P2860 Q37554942-22E73A51-3594-415B-951A-2013597A5FCE @default.
- Q37554942 P2860 Q37554942-26EC3DF8-CD25-458B-B315-E57EB1631F67 @default.
- Q37554942 P2860 Q37554942-28C2C2CE-C32A-4877-AB3D-E1E0C9974135 @default.
- Q37554942 P2860 Q37554942-2FE46977-35B3-4848-A709-D23E428D7D76 @default.
- Q37554942 P2860 Q37554942-38272CD5-CA81-4862-9B5B-8B28DEF4F3A6 @default.
- Q37554942 P2860 Q37554942-431614A4-CDEE-4833-8D02-C00275B34776 @default.
- Q37554942 P2860 Q37554942-5445B13E-AED9-4DD2-B6D2-6283CA5BBF9E @default.
- Q37554942 P2860 Q37554942-5B4B8F1A-265E-482F-AAD0-FA5D423DBE89 @default.
- Q37554942 P2860 Q37554942-67F43CDD-3F08-4531-8EDA-809E25F2F7E3 @default.
- Q37554942 P2860 Q37554942-6C5D94D1-02BC-496E-A1FF-5F35AA8556B4 @default.
- Q37554942 P2860 Q37554942-6D4A6BF7-725F-450C-9E28-AF31C1A773E4 @default.
- Q37554942 P2860 Q37554942-757716ED-41D7-4D24-A885-50F506145098 @default.
- Q37554942 P2860 Q37554942-855AF38E-1EA9-41A7-A8DB-60053AEC1F7C @default.
- Q37554942 P2860 Q37554942-8AB25364-26E8-4998-A2CB-910755B269B5 @default.
- Q37554942 P2860 Q37554942-8C155418-0F82-4C3E-85E9-A43DD8A6547C @default.
- Q37554942 P2860 Q37554942-8DB9FEF5-98D7-4BC0-87B7-E5FD734A15CC @default.
- Q37554942 P2860 Q37554942-94B56B5B-1FAB-48D8-9D66-35C7E9D78704 @default.
- Q37554942 P2860 Q37554942-9F48D02E-19DA-4255-A5DF-CA756CA2E665 @default.
- Q37554942 P2860 Q37554942-9FAFED51-0572-42C0-86D8-5A57B6E73E59 @default.
- Q37554942 P2860 Q37554942-ADD64C01-28A4-4249-B23C-225A775673C8 @default.
- Q37554942 P2860 Q37554942-C6A56012-84CF-4BF1-808C-78769AC4C117 @default.
- Q37554942 P2860 Q37554942-D3EAD7EF-AF65-4DFF-BA1F-135351CE9E90 @default.
- Q37554942 P2860 Q37554942-DBA19BB6-E4AA-46FD-8327-BA896EF4084A @default.
- Q37554942 P2860 Q37554942-E675C24C-F475-4987-B494-0F7853A1F65A @default.
- Q37554942 P2860 Q37554942-ED5373AE-66DB-48A9-B75E-D13681A99472 @default.
- Q37554942 P2860 Q37554942-F985A343-313F-415B-AEFE-522B760436A7 @default.
- Q37554942 P2888 Q37554942-C026922B-D359-49E9-8826-7E3FF6F0E0DD @default.
- Q37554942 P304 Q37554942-3041D9FC-F50F-44FC-9EC2-133130B5EB94 @default.
- Q37554942 P31 Q37554942-130DB2AD-0248-4B63-AEE1-A13F737A7F30 @default.
- Q37554942 P356 Q37554942-499428B8-931C-40B3-AD81-0F0288FF610C @default.
- Q37554942 P433 Q37554942-FC88134A-DA61-48DB-A36C-FDB83D2307E3 @default.
- Q37554942 P478 Q37554942-0733B68B-FF08-4E11-A6BF-F210810562AB @default.
- Q37554942 P577 Q37554942-10C2BEA2-711E-4C80-B9E1-925EF2FB6759 @default.
- Q37554942 P5875 Q37554942-7726668C-25C7-436B-92CC-28C62991EDFB @default.
- Q37554942 P6216 Q37554942-10fe087c-2cc8-4e45-99b9-0c1f8801fcbe @default.
- Q37554942 P698 Q37554942-02774FE1-FB0A-43A8-9924-3A3A0E285CD0 @default.
- Q37554942 P921 Q37554942-52088EA9-16BB-40D1-BF6E-46B0CEE5B29B @default.
- Q37554942 P921 Q37554942-B893862A-AAD4-4859-A3FC-AB68EBB52263 @default.
- Q37554942 P932 Q37554942-4AF10919-93E9-4E87-B650-7AC5B04B21CB @default.
- Q37554942 P356 S10637-013-9988-X @default.
- Q37554942 P698 23817974 @default.
- Q37554942 P1433 Q2312231 @default.
- Q37554942 P1476 "Phase 1 dose-escalation, pharmacokinetic, and cerebrospinal fluid distribution study of TAK-285, an investigational inhibitor of EGFR and HER2." @default.
- Q37554942 P2093 "Dennis Noe" @default.
- Q37554942 P2093 "E Gabriela Chiorean" @default.
- Q37554942 P2093 "Edward A Sausville" @default.
- Q37554942 P2093 "Jing-Tao Wu" @default.
- Q37554942 P2093 "Karthik Venkatakrishnan" @default.
- Q37554942 P2093 "Maria Corvez" @default.
- Q37554942 P2093 "Patricia LoRusso" @default.
- Q37554942 P2093 "Serap Sankoh" @default.
- Q37554942 P275 Q44128984 @default.
- Q37554942 P2860 Q27667382 @default.
- Q37554942 P2860 Q27675102 @default.
- Q37554942 P2860 Q27824766 @default.
- Q37554942 P2860 Q27851691 @default.
- Q37554942 P2860 Q27860693 @default.
- Q37554942 P2860 Q27860904 @default.
- Q37554942 P2860 Q28263537 @default.
- Q37554942 P2860 Q29617440 @default.